Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 64
Filtrar
2.
Rev. esp. anestesiol. reanim ; 70(6): 362-365, Jun-Jul. 2023. tab
Artículo en Español | IBECS | ID: ibc-221252

RESUMEN

Paciente de 26 años afecto de ataxia de Friederich con una miocardiopatía hipertrófica no obstructiva sometido a una tiroidectomía total por una tirotoxicosis secundaria a amiodarona persistente (a pesar de elevadas dosis de antitiroideos y corticoides), que intraoperatoriamente presentó un episodio sugestivo de tormenta tiroidea.La tormenta tiroidea es una urgencia endocrinológica que asocia una elevada morbimortalidad. Para mejorar la supervivencia es de vital importancia un diagnóstico temprano y un tratamiento precoz que incluya: un tratamiento sintomático, el tratamiento de las manifestaciones cardiovasculares, neurológicas y/o hepáticas y de la tirotoxicosis, así como suprimir o evitar estímulos desencadenantes y practicar un tratamiento definitivo.(AU)


A 26-year-old patient with Friederich's ataxia with hypertrophic obstructive cardiomyopathy undergoing a total thyroidectomy due to persistent amiodarone-induced thyrotoxicosis (despite high doses of antithyroid drugs and corticosteroids), presented an intraoperative episode suggestive of thyroid storm.Thyroid storm is an endocrine emergency that is associated with high morbimortality. Early diagnosis and treatment, which is of vital importance to improve survival. Treatment includes: symptomatic treatment, treatment of cardiovascular, neurological, and/or hepatic manifestations and thyrotoxicosis, measures to suppress or avoid triggering stimuli, and definitive treatment.(AU)


Asunto(s)
Humanos , Masculino , Adulto , Ataxia de Friedreich/complicaciones , Ataxia de Friedreich/tratamiento farmacológico , Crisis Tiroidea/complicaciones , Crisis Tiroidea/tratamiento farmacológico , Cardiomiopatía Hipertrófica , Tirotoxicosis , Amiodarona , Anestesia , Anestesiología , Resultado del Tratamiento , Pacientes Internos , Examen Físico , Evaluación de Síntomas
3.
Artículo en Inglés | MEDLINE | ID: mdl-37276964

RESUMEN

A 26-year-old patient with Friederich's ataxia with hypertrophic obstructive cardiomyopathy undergoing total thyroidectomy due to persistent amiodarone-induced thyrotoxicosis (despite high doses of antithyroid drugs and corticosteroids), presented an intraoperative episode suggestive of thyroid storm. Thyroid storm is an endocrine emergency that is associated with high morbidity and mortality. Early diagnosis and treatment, which is of vital importance to improve survival, includes symptomatic treatment, treatment of cardiovascular, neurological, and/or hepatic manifestations and thyrotoxicosis, measures to suppress or avoid triggering stimuli, and definitive treatment.


Asunto(s)
Anestésicos , Crisis Tiroidea , Tirotoxicosis , Humanos , Adulto , Crisis Tiroidea/complicaciones , Crisis Tiroidea/diagnóstico , Crisis Tiroidea/tratamiento farmacológico , Tirotoxicosis/complicaciones , Tirotoxicosis/cirugía , Tirotoxicosis/inducido químicamente , Ataxia/complicaciones , Ataxia/tratamiento farmacológico , Antitiroideos/efectos adversos , Anestésicos/efectos adversos
8.
J Investig Allergol Clin Immunol ; 33(3): 179-189, 2023 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-35029151

RESUMEN

OBJECTIVES: To assess the degree of consensus among a multidisciplinary expert panel on the transition of adolescents with severe asthma from pediatric to adult care. METHODS: A 61-item survey was developed based on guidelines for other chronic diseases, covering transition planning, preparation, effective transfer, and follow-up. A 2-round Delphi process assessed the degree of consensus among 98 experts (49 pediatricians, 24 allergists, and 25 pulmonologists). Consensus was established with ≥70% agreement. RESULTS: Consensus was reached for 42 items (70%). Panelists were unable to agree on an age range for initiation of transition. The main goal during the transition identified by the experts is for adolescents to gain autonomy in managing severe asthma and prescribed treatments. The panelists agreed on the importance of developing an individualized plan, promoting patient autonomy, and identifying factors associated with the home environment. They agreed that the adult health care team should have expertise in severe asthma, biologics, and management of adolescent patients. Pediatric and adult health care teams should share clinical information, agree on the criteria for maintaining biological therapy, and have an on-site joint visit with the patient before the effective transfer. Adult health care professionals should closely follow the patient after the effective transfer to ensure correct inhaler technique, adherence, and attendance at health care appointments. CONCLUSION: This consensus document provides the first roadmap for Spanish pediatric and adult teams to ensure that key aspects of the transition process in severe asthma are covered. The implementation of these recommendations will improve the quality of care offered to the patient.


Asunto(s)
Asma , Transición a la Atención de Adultos , Humanos , Adolescente , Adulto , Niño , Consenso , España , Asma/tratamiento farmacológico , Terapia Biológica
9.
J Investig Allergol Clin Immunol ; 32(4): 270-281, 2022 Jul 22.
Artículo en Inglés | MEDLINE | ID: mdl-33884956

RESUMEN

BACKGROUND AND OBJECTIVE: Nut allergy is a growing problem, yet little is known about its onset in children. Objective: To characterize the onset of nut allergy in children in southern Europe. METHODS: The study population comprised consecutive patients up to 14 years of age who visited allergy departments with an initial allergic reaction to peanut, tree nut, or seed. The allergy work-up included a clinical history, food challenge, skin prick testing, determination of whole-extract sIgE, and ImmunoCAP ISAC-112 assay. RESULTS: Of the 271 children included, 260 were first diagnosed with nut allergy at a mean age of 6.5 years and at a mean (SD) of 11.8 (21.2) months after the index reaction. The most common culprit nuts at onset were walnut (36.5%), peanut (28.5%), cashew (10.4%), hazelnut (8.5%), pistachio (5.4%), and almond (5%). Onset of peanut allergy was more frequent in children ≤6 years and walnut in those aged >6 years (P=.032). In 65% of cases, the allergic reaction occurred the first time the patient consumed the nut, and 35% of reactions were anaphylactic. Overall, polysensitization to nuts was detected by skin prick testing in 64.9% of patients, although this rate was lower among walnut-allergic children (54.7%) and peanut-allergic children (54.1%) (P<.0001). Sensitization to 2S albumins was predominant (75%), especially Jug r 1 (52.8%), whereas sensitization to lipid transfer proteins was less relevant (37%). CONCLUSION: In the population we assessed, the onset of nut allergy occurred around 6 years of age, slightly later than that reported in English-speaking countries. Walnut was the main trigger, followed by peanut. 2S albumin storage proteins, especially Jug r 1, were the most relevant allergens. This study will help guide management and may contribute to preventive strategies in pediatric nut allergy.


Asunto(s)
Juglans , Hipersensibilidad a la Nuez , Hipersensibilidad al Cacahuete , Alérgenos , Arachis , Niño , Humanos , Inmunoglobulina E , Hipersensibilidad a la Nuez/diagnóstico , Hipersensibilidad a la Nuez/epidemiología , Nueces , Hipersensibilidad al Cacahuete/diagnóstico , Pruebas Cutáneas
13.
J Investig Allergol Clin Immunol ; 29(2): 94-102, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30457105

RESUMEN

The emergence of new technology enables allergists and patients to compile data and receive feedback regarding key symptoms, risk behavior, and/or management. The term "eHealth" refers to a diverse group of tools that use computerized technologies to improve both the efficacy and the efficiency of the health care industry. eHealth comprises a variety of technologies, as follows: mobile devices (mHealth) in medical care, including electronic diaries, wearable sensors, and adherence monitoring; health informatics (eg, electronic health records, computerized physician order entry, clinical decision support); telemedicine, which is the use of information and communication technologies for the management of diseases and medical education; social media platforms, and the analysis of information acquired through these platforms using "big data" technologies. In this review, we summarize the latest findings on the use of eHealth technology and the relevance of eHealth to allergic conditions.


Asunto(s)
Hipersensibilidad , Informática Médica , Telemedicina , Humanos , Hipersensibilidad/diagnóstico , Hipersensibilidad/epidemiología , Hipersensibilidad/prevención & control , Hipersensibilidad/terapia , Informática Médica/métodos , Medios de Comunicación Sociales , Telemedicina/métodos
15.
J. investig. allergol. clin. immunol ; 29(2): 94-102, 2019. ilus, tab, graf
Artículo en Inglés | IBECS | ID: ibc-184051

RESUMEN

The emergence of new technology enables allergists and patients to compile data and receive feedback regarding key symptoms, risk behavior, and/or management. The term "eHealth" refers to a diverse group of tools that use computerized technologies to improve both the efficacy and the efficiency of the health care industry. eHealth comprises a variety of technologies, as follows: mobile devices (mHealth) in medical care, including electronic diaries, wearable sensors, and adherence monitoring; health informatics (eg, electronic health records, computerized physician order entry, clinical decision support); telemedicine, which is the use of information and communication technologies for the management of diseases and medical education; social media platforms, and the analysis of information acquired through these platforms using "big data" technologies.In this review, we summarize the latest findings on the use of eHealth technology and the relevance of eHealth to allergic conditions


La aparición de nuevas tecnologías conlleva para los alergólogos y los pacientes la posibilidad de recopilar datos y recibir información directa sobre los síntomas clave de las enfermedades, los comportamientos de riesgo y/o su manejo. El término "eHealth", o salud electrónica, se refiere a un grupo diverso de herramientas que utilizan tecnologías informáticas para mejorar la eficacia y la eficiencia de la industria de la salud. La "eHealth" comprende varias tecnologías, como el uso de dispositivos móviles aplicados a la salud ("mHealth"), incluyendo diarios electrónicos, sensores ponibles o monitorización de la adherencia terapéutica; la informática biomédica (por ejemplo, la historia clínica electrónica, la prescripción electrónica o los sistemas de ayuda a las decisiones clínicas); la telemedicina, que es el uso de las tecnologías de la información y la comunicación para el manejo de enfermedades y de educación sanitaria; las plataformas de redes sociales, y el análisis de la información adquirida a través de estas plataformas, usando técnicas de "big data" o inteligencia de datos. En esta revisión, resumimos la evidencia que rodea al uso de tecnologías "eHealth" y su relevancia para las enfermedades alérgicas


Asunto(s)
Humanos , Telemedicina/tendencias , Asma/tratamiento farmacológico , Consulta Remota/tendencias , Hipersensibilidad/tratamiento farmacológico , Asma/diagnóstico , Aplicaciones Móviles/tendencias , Macrodatos/provisión & distribución , Políticas de eSalud , Red Social , Hipersensibilidad/diagnóstico
19.
Radiología (Madr., Ed. impr.) ; 60(2): 171-174, mar.-abr. 2018. ilus
Artículo en Español | IBECS | ID: ibc-174079

RESUMEN

La inflamación de las glándulas salivales secundaria a la administración de contraste yodado es una reacción adversa muy poco frecuente. Su etiología no está aclarada y, aunque tiene un curso benigno, se han descrito complicaciones asociadas. Presentamos dos casos de submaxilitis aguda bilateral como reacción adversa tras la administración intravenosa de contraste yodado en dos varones de 60 y 63 años de edad a los que se realizó en los días previos una tomografía computarizada


Swelling of the salivary glands after administration of iodinated contrast is a very rare adverse reaction. Its etiology is not clear and although it has a benign course associated complications have been reported. We report two cases of acute bilateral sialadenitis after intravenous iodinated contrast in 60 and 63 year-old men who underwent a computed tomography scan in the previous days


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Sialadenitis/complicaciones , Sialadenitis/diagnóstico por imagen , Compuestos de Yodo/efectos adversos , Corticoesteroides/uso terapéutico , Sialadenitis/inducido químicamente , Glándulas Salivales , Glándulas Salivales/diagnóstico por imagen , Medios de Contraste/efectos adversos , Vértebras Cervicales/diagnóstico por imagen , Vértebras Cervicales/lesiones , Diagnóstico Diferencial
20.
Artículo en Inglés | MEDLINE | ID: mdl-28760720

RESUMEN

Profilin is a protein that is present in all eukaryotic cells and is responsible for cross-reactivity between pollen, latex, and plant foods. It has been classically acknowledged as a minor or nearly irrelevant allergen, although recent data are changing this conception. The objective of this manuscript is to provide a comprehensive review of published data on the role of this ubiquitous allergen in pollen, latex, and plant food allergy. The patterns of recognition of this minor allergen follow a north-south gradient. Although present in all pollens and vegetables, profilin is significantly associated with allergy to grass pollen and to Cucurbitaceae fruits. Heb v 8, the latex profilin, is usually a marker of profilin allergy in plant food-allergic patients, although it has no clinical relevance in latex allergy. Sensitization to profilin jeopardizes the diagnosis of pollen allergy and selection of immunotherapy, and although component-resolved diagnosis can identify its impact, there are no tailored treatments available. In recent years, several new publications have shown how profilin should be taken into account and, under certain circumstances, considered a marker of severity, an allergen capable of inducing respiratory symptoms, and, in its natural purified form, a potential candidate for etiological treatment of food allergy. Current data on profilin strongly support the need for a shift in the previously accepted paradigm for this allergen. More research should be done to assess the real clinical impact of sensitization in specific populations and to develop therapeutic strategies.


Asunto(s)
Profilinas/inmunología , Alérgenos/inmunología , Hipersensibilidad a los Alimentos/inmunología , Humanos , Látex/inmunología , Hipersensibilidad al Látex/inmunología , Proteínas de Plantas/inmunología , Polen/inmunología , Rinitis Alérgica Estacional/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...